First to gain major laser eye surgery accreditation

Article

Ultralase has become the first and only national provider to have all its UK surgeons accredited by the Royal College of Ophthalmologists (RCOphth).

Ultralase has become the first and only national provider to have all its UK surgeons accredited by the Royal College of Ophthalmologists (RCOphth).

All refractive surgeons practising across Ultralase’s network of over 25 British clinics received the RCOphth 'Certificate in Laser Refractive Surgery' after undergoing strict assessments in areas such as surgical skills and patient management.

Research from a survey conducted by Optician magazine and the British Society for Refractive Surgery (September/October 2008) revealed that the experience of a surgeon is the number one factor people consider when choosing a clinic.

Kathy Evans, chief executive for the RCOphth, added: “The assessment was set up for the benefit of patients and we are delighted that the number of surgeons now obtaining the certificate has increased.”

Mark Korolkiewicz, clinical services director at Ultralase, said: “For our refractive surgeons to be certified by the RCOphth is testament to the high levels of skill, knowledge and expertise we can offer to patients.”

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.